This prospective study was designed to evaluate the prognostic value of the percentage of plasma lymphocytes in patients with diastolic dysfunction as well as systolic dysfunction of the left ventricle.
reported to be useful for determining the prognosis of patients with congestive heart failure. [2] [3] [4] [5] [6] [7] [8] [9] In these reports, however, most of the patients had left ventricular dysfunction with a low ejection fraction. Zile, et al suggested that patients who have signs and symptoms of heart failure and a normal left ventricular ejection fraction have left ventricular diastolic dysfunction. 10) Left ventricular diastolic dysfunction, as well as systolic dysfunction, may lead to congestive heart failure.
Previous reports have demonstrated that the sympathetic nervous or immune systems are activated in patients with congestive heart failure, 8, [11] [12] [13] which lead to a decrease in the percentage of plasma lymphocytes. [14] [15] [16] In these reports, however, most of the subjects had systolic dysfunction of the left ventricle. This prospective study was designed to evaluate the prognostic value of the percentage of plasma lymphocytes in patients, in particular, with preserved systolic function of the left ventricle.
METHODS
Patients: This is a prospective study of patients with congestive heart failure. The subjects consisted of 80 consecutive patients hospitalized in our institution from April 2001 to August 2002. Ten patients were excluded because they died during hospitalization due to worsening of the congestive heart failure. In the remaining 70 patients, none had experienced an infection, trauma, surgery, myocardial infarction, or glucocorticoid use within 8 weeks of their entry into the study, and none had a history of malignancy, radiation therapy, or chemotherapy. Under these conditions, the total and differential leukocyte counts could be altered. A diagnosis of congestive heart failure depended on the presence of the following symptoms; fatigability, exertional dyspnea, orthopnea, limitation of activity, a third heart sound, elevated jugular venous pressure, rales, and leg edema. Study design: Following an improvement in congestive heart failure, leukocyte differentiation, and plasma levels of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), norepinephrine, epinephrine, and dopamine were measured in blood samples drawn by venipuncture after the subjects had rested in a supine position for at least 30 minutes early in the morning.
We recorded the patient characteristics at the time of admission, including age, gender, complications (hypertension, hyperlipidemia, diabetes mellitus), history of smoking, etiology of congestive heart failure and medication use (digoxin, diuretics, angiotensin-converting enzyme inhibitor, calcium antagonist, beta-adrenergic blocker and nitrate), heart rate, and blood pressure. Analysis: Univariate analyses were performed using the Student t test, and categorical data were examined using a chi-square distribution. The prognostic value Vol 45 No 2 of the variables was tested using a Cox proportional hazard regression analysis. P values, relative risks, and associated confidence intervals were determined. Kaplan-Meier estimates of the nonevent functions were plotted for patients with high and low percentages of plasma lymphocytes. The correlation of the plasma BNP level and the percentage of plasma lymphocytes was examined using separate linear regression analyses in two groups based on the basal diseases; ischemic heart disease, dilated cardiomyopathy (DCM), aortic stenosis, aortic regurgitation, and mitral regurgitation group, and mitral stenosis, hypertensive heart disease, tachycardia with atrial fibrillation, and hypertrophic cardiomyopathy group. A decision concerning the basal disease depended on the disease which was the main cause of heart failure. Because there were few patients enrolled in this study who had several heart diseases, it was not difficult to determine the main cause of heart failure. The results are presented as the mean ± standard deviation. A value of P < 0.05 was considered statistically significant. Measurements of leukocyte differentiation and neurohumoral factors: The complete blood cell count analysis was performed with a commercially automated system (COULTER 700, Beckman Coulter Inc.) and used a sample size of 8,000 cells. The percentage of plasma lymphocytes was defined as (Total number of lymphocytes/Total leukocytes) × 100. In our institution, the normal range of the percentage of plasma lymphocytes is 21.0 to 45.0%.
Samples for the assay of plasma ANP and BNP concentrations were collected in chilled disposable tubes containing aprotinin (500 kallikrein inhibitor units/mL) and EDTA (1 mg/mL). The blood samples were immediately placed on ice and centrifuged at 4°C. Plasma ANP and BNP concentrations were measured with specific immunoradiometric assays. [3] [4] Samples for the assay of plasma epinephrine, norepinephrine, and dopamine concentrations were also collected in chilled disposable tubes containing EDTA. They were measured by high performance liquid chromatography (HPLC).
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RESULTS
Patient characteristics:
The study group consisted of 70 patients (34 men, 36 women, age range, 33 to 91, mean age, 72 ± 12 years). All patients and/or their families provided written informed consent for participation in the study. They were followed-up for 17 ± 9 months. During the follow-up period, 6 patients died (cardiac death) and 12 patients needed hospitalization due to a worsening of congestive heart failure. These 18 patients were regarded as the cardiac event group, while the others were included in the noncardiac event group. The patient characteristics are shown in Tables I and II . There were no differences in age or gender between the cardiac event and noncardiac event groups. The number of patients with a history of smoking among the cardiac event group was significantly larger, and the number of patients with hypertension was significantly less than among the noncardiac event group (P value = 0.04, 0.04, respectively). No significant differences were observed between the two groups with respect to medication for congestive heart failure, NYHA classification, and basal diseases. Univariate analysis: As shown in Table III , the plasma levels of ANP, norepinephrine, and epinephrine after treatment for congestive heart failure were not significantly different between the two groups. The plasma level of BNP in the cardiac event group was significantly larger than that in the noncardiac event group (402 ± 168 vs 153 ± 51 pg/mL, P = 0.04). The percentage of plasma lymphocytes in the cardiac event group was significantly less than in the noncardiac event group (24.7 ± 8.40 vs 33.3 ± 7.64%, P = 0.0006).
Multivariate analysis : The percentage of plasma lymphocytes after treatment for congestive heart failure was significantly associated with a cardiac event, even after adjusting for history of smoking and diagnosis of hypertension as well as age, gender, NYHA classification, and the plasma levels of norepinephrine, epinephrine, dopamine, ANP, and BNP (Odds ratio: 0.780, 95% confidence interval: 0.668-0.910, P = 0.001), as shown in Table IV . Kaplan-Meier event-free curve analysis: The patients were divided into two groups based on their percentage of plasma lymphocytes after treatment for con- gestive heart failure. The cut-off point was set at 21% based on the lowest limit. Kaplan-Meier event-free curves demonstrated that the patients with a percentage of plasma lymphocytes less than 21% had a significantly worse prognosis (P < 0.0001) (Figure 1) . Classification based on the basal disease : The subjects were divided into two groups: group A consisted of patients with ischemic heart disease, dilated cardiomyopathy, aortic stenosis, aortic regurgitation, or mitral regurgitation, in which they had low contractile function (fractional shortening 25 ± 13% by echocardiography), and group B included the other patients with hypertensive heart disease, mitral stenosis, hypertrophic cardiomyopathy, or tachycardia with atrial fibrillation, in which they preserved contractile function (fractional shortening 33 ± 10%). Generally, in patients with aortic or mitral regurgitation, the contractile function of the left ventricle is reduced at a decompensated stage, so that in this study these patients were classified into the systolic dysfunction group. In both groups A and B, the percentage of plasma lymphocytes of the cardiac event group was significantly lower than that of the noncardiac event group, although the plasma level of BNP in the cardiac event group was significantly higher than that in the noncardiac event group only in group A (Table V) . The relationship between the percentage of plasma lymphocytes and plasma BNP level is shown in Figure 2 . A negative linear low correlation (r = -0.43, P = 0.011) was present in group A, but not in group B (r = -0.17, P = 0.393). 
DISCUSSION
In the present study, we have shown that the percentage of plasma lymphocytes can be used as a prognostic marker in patients with diastolic as well as systolic heart failure. Various neurohumoral factors, such as BNP, 4) interleukin-6, 2-3) norepinephrine, 5) and the percentage of plasma lymphocytes, [14] [15] [16] have been reported to be useful for determining the prognosis in patients with congestive heart failure. Although most of these reports enrolled subjects mainly with abnormal contractile function of the left ventricle, the present study included patients with diastolic dysfunction (hypertensive heart disease, tachycardia with atrial fibrillation, hypertrophic cardiomyopathy) as well as patients with systolic dysfunction.
Tsutamoto and colleagues reported that in 85 patients with chronic congestive heart failure the plasma BNP level provided prognostic information.
3) All of the subjects enrolled in their study had a low ejection fraction (< 0.45). The etiologies of heart failure were ischemic heart disease (45%), dilated cardiomyopathy (45%), and hypertensive heart disease (4%). In their study, most of the subjects had abnormal systolic function. Only a few had diastolic dysfunction alone.
Cheung, et al examined patients with diastolic dysfunction but normal ejection fraction. The plasma BNP level correlated with the E/A ratio and they concluded that the plasma BNP level was influenced by diastolic function. 18) In their report, however, patients with diastolic dysfunction were restricted to those with hypertensive heart disease. Lubien, et al reported that in patients with normal systolic function, elevated BNP (> 62 pg/mL) may indicate the presence of diastolic abnormalities determined by echocardiography. 19) However, the etiology of diastolic dysfunction was unknown and its usefulness as a prognostic marker was uncertain.
Regarding the percentage of plasma lymphocytes, Acanfora, et al reported that in elderly patients with congestive heart failure a low relative lymphocyte count was an independent marker of a poor prognosis.
16) The etiologies of heart failure in their study were ischemic heart disease (43%), dilated cardiomyopathy (6%), valvular heart disease (28%), hypertensive heart disease (27%), and others (4%). Some of their subjects had diastolic dysfunction as well as systolic dysfunction.
In the present study, the subjects were divided into two groups based on their basal diseases; (A) subjects with mainly systolic dysfunction and (B) subjects with preserved systolic function but most likely impaired diastolic function. In conclusion, the percentage of plasma lymphocytes was significantly different between the cardiac event and noncardiac event groups regardless of whether they had preserved systolic function or not, although the plasma level of BNP showed a significant difference only in the low contractile function group. Moreover, low plasma lymphocytes may be a prognostic marker for congestive heart failure. In patients with congestive heart failure, the sympathetic nervous system is activated, which leads to the secretion of cortisol and catecholamines, and a reduction in the number of lymphocytes in plasma. In the present study, norepi -Vol 45  No 2 nephrine, epinephrine, and dopamine levels were higher in the cardiac event group. Cortisol has a very short half-life and a pulsatile pattern of secretion so its measurement is difficult.
As shown in Figure 2 , in patients with systolic dysfunction, a negative correlation between their plasma BNP level and percentage of plasma lymphocytes was observed. In contrast, no correlation was seen in patients with preserved contractile function. These findings may suggest that the plasma BNP level is a prognostic marker for patients with systolic dysfunction, but not for patients with preserved systolic function, as demonstrated in most previous reports. The percentage of plasma lymphocytes may be a useful prognostic marker for patients with diastolic dysfunction, preserved contractile function, as well as systolic dysfunction of the left ventricle.
We separated patients with congestive heart failure into two groups on the basis of their basal diseases. Accordingly, it may be sometimes difficult to judge whether these patients complain more frequently about systolic or diastolic function. A previous report found that one quarter of patients with heart failure but preserved systolic function determined by conventional echocardiographic measurements have heart failure caused by subtle systolic dysfunction detected by measuring left ventricular systolic function -atrioventricular plane displacement. 20, 21) The value of the percentage of plasma lymphocytes is quite different from that of BNP, which is mainly secreted from the cardiac ventricles. The plasma BNP level directly reflects the cardiac condition. On the contrary, the percentage of plasma lymphocytes may reflect total body condition, in some time, mediated by cardiac condition. Therefore, the percentage of plasma lymphocytes may not indicate whether the main cause of heart failure is systolic or diastolic dysfunction. Study limitations: There are two major limitations to this study. First, only half of the patients in both the cardiac event and noncardiac event groups were treated with ACE inhibitors. The reasons were side effects such as cough and hypotension, or existing renal dysfunction. β-Blockers could be introduced in only 16% of the patients in the cardiac event group. All patients enrolled in this study had been admitted to hospital due to worsening congestive heart failure, and some unavoidably stopped receiving β-blockers. However, there were no significant differences between the two groups. On the other hand, the number of patients treated with digoxin was larger in the cardiac event group than in the noncardiac event group. In a situation of severely decreased cardiac performance, digoxin was easier to introduce than β-blockers.
Second, patients with preserved systolic function were judged to have impaired diastolic function. Although diastolic function should have been exam-ined by echocardiography, this was impossible because of the large number of patients who suffered from atrial fibrillation.
